MFGNN-DSA:一种通过多特征融合和图形神经网络预测药物副作用关联的模型
Longyue Chen1, Yunhe Tian1, Jialin Yang1,2
1Institute of Computational Medicine, School of Artificial Intelligence, Hebei University of Technology, Tianjin 300401, China.
Journal of chemical information and modeling
|October 20, 2025
概括
新型多特征图形神经网络MFGNN-DSA通过整合各种生物医学数据,准确预测药物副作用的关联. 该框架增强了药物发现和安全性评估,优于现有方法.
科学领域:
- 药理学 药理学是指药理学的学科.
- 生物信息学是一种生物信息学.
- 计算生物学 计算生物学
背景情况:
- 准确预测与药物相关的不良副作用对于药物发现和安全至关重要.
- 现有的模型往往无法捕捉药物和副作用之间的复杂关系,因为它们专注于单一的属性.
研究的目的:
- 开发一种新的多特征图形神经网络框架,MFGNN-DSA,以更好地预测药物副作用关联.
- 整合异构的生物医学信息,以便更全面地了解药物副作用关系.
主要方法:
- 提取药物和副作用的多源特征,并将其集成到基于属性的载体中,使用图表采样和聚合.
- 构建疾病,药物和副作用的异质网络,使用HIN2Vec.ec.得出的拓特征.
- 采用多头自我注意机制来结合拓学,基于属性和聚合特征的最终预测.
主要成果:
- 与最先进的方法相比,MFGNN-DSA表现出更高的性能,获得更高的AUC和AUPR得分.
- 实验结果和案例研究验证了该模型在预测药物副作用关联方面的有效性.
结论:
- 该MFGNN-DSA框架提供了一个强大的和准确的方法来预测药物副作用的关联.
- 这一进步具有改善药物安全性评估和加速药物发现过程的巨大潜力.
相关概念视频
Combined Effects of Drugs: Synergism
6.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
6.7K
Combined Effects of Drugs: Antagonism
11.5K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
11.5K
Factors Affecting Drug Response: Overview
3.0K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
3.0K
Drug-Receptor Interactions
7.3K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
7.3K
Quantitative Aspects of Drug-Receptor Interaction
1.7K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.7K
Drug Concentration Versus Time Correlation
2.0K
The plasma drug concentration-time curve is a crucial tool in pharmacokinetics, representing the drug's concentration in plasma at different time intervals post-administration. This curve illustrates the drug's journey from absorption into the systemic circulation, distribution to body tissues, and eventual elimination through excretion or biotransformation.
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
2.0K


